ENSG moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 31 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on ENSG as a result. In 59 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for ENSG just turned positive on October 28, 2026. Looking at past instances where ENSG's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
The 10-day moving average for ENSG crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +5.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENSG advanced for three days, in 197 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENSG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
ENSG broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 25 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. ENSG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.322) is normal, around the industry mean (204.532). P/E Ratio (27.562) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.391) is also within normal values, averaging (2.498). Dividend Yield (0.001) settles around the average of (0.154) among similar stocks. P/S Ratio (1.925) is also within normal values, averaging (2.688).
THC saw its Momentum Indicator move above the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 67 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.
The Moving Average Convergence Divergence (MACD) for THC just turned positive on November 04, 2026. Looking at past instances where THC's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
THC moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for THC crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where THC advanced for three days, in 262 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 222 of 264 cases where THC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The 10-day RSI Indicator for THC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator moved out of overbought territory. In 32 of the 54 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where THC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
THC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. THC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.898) is normal, around the industry mean (204.532). P/E Ratio (10.872) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.789) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.022) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ENSG | THC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 25 | 10 | |
SMR RATING 1..100 | 52 | 20 | |
PRICE GROWTH RATING 1..100 | 48 | 38 | |
P/E GROWTH RATING 1..100 | 67 | 75 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
THC's Valuation (69) in the Hospital Or Nursing Management industry is in the same range as ENSG (78) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to ENSG’s over the last 12 months.
THC's Profit vs Risk Rating (10) in the Hospital Or Nursing Management industry is in the same range as ENSG (25) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to ENSG’s over the last 12 months.
THC's SMR Rating (20) in the Hospital Or Nursing Management industry is in the same range as ENSG (52) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to ENSG’s over the last 12 months.
THC's Price Growth Rating (38) in the Hospital Or Nursing Management industry is in the same range as ENSG (48) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to ENSG’s over the last 12 months.
ENSG's P/E Growth Rating (67) in the Medical Or Nursing Services industry is in the same range as THC (75) in the Hospital Or Nursing Management industry. This means that ENSG’s stock grew similarly to THC’s over the last 12 months.
| ENSG | THC | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 59% |
| Stochastic ODDS (%) | 4 days ago 52% | 4 days ago 65% |
| Momentum ODDS (%) | 4 days ago 65% | 4 days ago 85% |
| MACD ODDS (%) | 4 days ago 69% | 4 days ago 82% |
| TrendWeek ODDS (%) | 4 days ago 57% | 4 days ago 80% |
| TrendMonth ODDS (%) | 4 days ago 65% | 4 days ago 78% |
| Advances ODDS (%) | 6 days ago 66% | 11 days ago 82% |
| Declines ODDS (%) | 4 days ago 54% | 4 days ago 66% |
| BollingerBands ODDS (%) | 4 days ago 49% | 4 days ago 56% |
| Aroon ODDS (%) | N/A | 4 days ago 84% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENSG’s FA Score shows that 1 FA rating(s) are green while THC’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENSG’s TA Score shows that 5 TA indicator(s) are bullish while THC’s TA Score has 6 bullish TA indicator(s).
ENSG (@Hospital/Nursing Management) experienced а -0.24% price change this week, while THC (@Hospital/Nursing Management) price change was +3.69% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.34%. For the same industry, the average monthly price growth was +2.28%, and the average quarterly price growth was +11.65%.
ENSG is expected to report earnings on Feb 10, 2027.
THC is expected to report earnings on Feb 11, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, ENSG has been loosely correlated with EHC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSG jumps, then EHC could also see price increases.
| Ticker / NAME | Correlation To ENSG | 1D Price Change % | ||
|---|---|---|---|---|
| ENSG | 100% | -0.72% | ||
| EHC - ENSG | 42% Loosely correlated | -2.64% | ||
| HCA - ENSG | 42% Loosely correlated | -2.46% | ||
| PNTG - ENSG | 42% Loosely correlated | -9.10% | ||
| ADUS - ENSG | 36% Loosely correlated | -1.97% | ||
| CHE - ENSG | 32% Poorly correlated | -1.07% | ||
More | ||||
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BJUN | 48.35 | 0.07 | +0.14% |
| Innovator U.S. Equity Buffer ETF - June (BJUN) | |||
| VCIT | 79.77 | -0.10 | -0.13% |
| Vanguard Intermediate-Term Corporate Bond ETF (VCIT) | |||
| TILC | 24.40 | -0.15 | -0.63% |
| Thrivent International Large Cap ETF (TILC) | |||
| VDV | 74.87 | -0.66 | -0.88% |
| Vanguard Developed Markets ex-US Value Index ETF (VDV) | |||
| NVDS | 23.23 | -0.98 | -4.05% |
| Tradr 1.5X Short NVDA Daily ETF (NVDS) | |||